Diego Allonso Rodrigues dos Santos da Silva

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Biotecnologia Farmacêutica

ORCID:

não disponível no Lattes


Formação:

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2014 - 2015

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 2010 - 2014

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Mestrado | 2008 - 2010

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas - Modalidade Médica | Graduação | 2005 - 2008
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(100.00% artigos com DOI)

Titulo DOI Ano
In silico Analysis of Natural Products from Brazilian Biodiversity in COVID-19 Treatment: NuBBE Database against SARS-CoV-2 Papain-Like Protease 10.21577/0103-5053.20230173 2024
SARS-CoV-2 spike protein increases angiotensin converting-2 expression and promotes an increase in glucose uptake in endothelial cells 10.3389/av.2024.12136 2024
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro 10.1038/s41598-024-59292-0 2024
Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro) 10.1038/s41598-024-59442-4 2024
Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors 10.3390/ph17040436 2024
High mobility group box 1, ATP , lipid mediators, and tissue factor are elevated in COVID ¿19 patients: HMGB1 as a biomarker of worst prognosis 10.1111/cts.13475 2023
Marine Natural Products in the Battle against Dengue, Zika, and Chikungunya Arboviruses 10.21577/0103-5053.20230012 2023
In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases 10.1016/j.csbj.2023.02.020 2023
Diabetogenic viruses: linking viruses to diabetes mellitus 10.1016/j.heliyon.2023.e15021 2023
Anti-SARS-CoV-2 Activity of Ampelozizyphus amazonicus (Saracura-Mirá): Focus on the Modulation of the Spike-ACE2 Interaction by Chemically Characterized Bark Extracts by LC-DAD-APCI-MS/MS 10.3390/molecules28073159 2023
From metabolism to disease: the biological roles of glutamine:fructose-6-phosphate amidotransferase (GFAT) 10.1515/pac-2023-0503 2023
Antiviral, Cytoprotective, and Anti-Inflammatory Effect of Ampelozizyphus amazonicus Ducke Ethanolic Wood Extract on Chikungunya Virus Infection 10.3390/v15112232 2023
Increased circulating levels of High Mobility Group Box 1 (HMGB1) in acute-phase Chikungunya virus infection: potential disease biomarker 10.1016/j.jcv.2021.105054 2022
Nitrogen-Based Heterocyclic Compounds: A Promising Class of Antiviral Agents against Chikungunya Virus 10.3390/life11010016 2021
Enzymatic and structural properties of human glutamine:fructose-6-phosphate amidotransferase 2 (hGFAT2) 10.1074/jbc.ra120.015189 2021
ApoA1 neutralizes pro-inflammatory effects of Dengue virus NS1 protein and modulates the viral immune evasion 10.1128/JVI.01974-20 2021
Overview on Chikungunya virus infection: from epidemiology to state-of-the-art experimental models 10.3389/fmicb.2021.744164 2021
Dengue virus nonstructural 3 protein interacts directly with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and reduces its glycolytic activity 10.1038/s41598-019-39157-7 2019
Expression of soluble, glycosylated and correctly folded dengue virus NS1 protein in Pichia pastoris 10.1016/j.pep.2019.05.003 2019
Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis 10.3389/fimmu.2018.01979 2018
Dengue fatal cases present virus-specific HMGB1 response in peripheral organs 10.1038/s41598-017-16197-5 2017
Inhibition of the membrane attack complex by dengue NS1 through interaction with vitronectin and terminal complement proteins 10.1128/JVI.00912-16 2016
Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity 10.1128/jvi.01342-15 2015
Assessing Positivity and Circulating Levels of NS1 in Samples from a 2012 Dengue Outbreak in Rio de Janeiro, Brazil 10.1371/journal.pone.0113634 2014
Mapping the Interactions of Dengue Virus NS1 Protein with Human Liver Proteins Using a Yeast Two-Hybrid System: Identification of C1q as an Interacting Partner 10.1371/journal.pone.0057514 2013
High Mobility Group Box 1 Protein as an Auxiliary Biomarker for Dengue Diagnosis 10.4269/ajtmh.2012.12-0619 2013
Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection 10.1016/j.jcv.2012.07.010 2012
Polyclonal antibodies against properly folded Dengue virus NS1 protein expressed in E. coli enable sensitive and early dengue diagnosis 10.1016/j.jviromet.2011.04.029 2011
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: